• 1. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

Professional Introduction to 3-bromoimidazo[1,2-c]pyrimidine (CAS No: 1289007-18-6)

3-bromoimidazo[1,2-c]pyrimidine, with the chemical formula C?H?BrN?, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the imidazopyrimidine class, a structural motif known for its broad spectrum of biological activities. The presence of a bromine substituent at the 3-position enhances its utility as a versatile intermediate in synthetic chemistry, particularly in the development of novel therapeutic agents.

The significance of 3-bromoimidazo[1,2-c]pyrimidine lies in its potential applications across various domains of chemical biology and drug discovery. Its unique structural framework allows for facile modifications, making it a valuable scaffold for designing molecules with targeted biological effects. Recent advancements in medicinal chemistry have highlighted its role as a key precursor in the synthesis of small-molecule inhibitors and activators.

In the realm of oncology research, 3-bromoimidazo[1,2-c]pyrimidine has been extensively studied for its potential as an anti-cancer agent. The imidazopyrimidine core is known to interact with specific biological pathways involved in tumor growth and proliferation. Studies have demonstrated that derivatives of this compound can inhibit kinases and other enzymes critical for cancer cell survival. For instance, modifications at the bromine substituent have been shown to enhance binding affinity to target proteins, leading to more potent pharmacological outcomes.

Moreover, the compound has shown promise in preclinical trials as a component of combination therapies. Its ability to modulate multiple signaling pathways simultaneously makes it an attractive candidate for addressing complex diseases such as cancer. Researchers have explored its interactions with proteins involved in DNA repair and cell cycle regulation, suggesting that it may serve as a basis for developing next-generation chemotherapeutic agents.

The synthetic accessibility of 3-bromoimidazo[1,2-c]pyrimidine is another factor contributing to its widespread use in research. The bromine atom provides a handle for further functionalization through cross-coupling reactions like Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex molecular architectures, enabling the creation of diverse libraries of bioactive compounds. The compound’s versatility has also been leveraged in the development of probes for biochemical assays, aiding in the study of enzyme mechanisms and drug interactions.

Recent publications have highlighted novel applications of 3-bromoimidazo[1,2-c]pyrimidine in neurodegenerative disease research. The imidazopyrimidine scaffold has been found to exhibit neuroprotective properties by modulating neurotransmitter receptors and inhibiting oxidative stress pathways. This opens up avenues for exploring its potential as a therapeutic intervention in conditions such as Alzheimer’s disease and Parkinson’s disease. The ability to fine-tune its pharmacological profile through structural modifications offers hope for developing treatments that address specific pathological mechanisms.

In addition to its pharmaceutical applications, 3-bromoimidazo[1,2-c]pyrimidine has found utility in materials science and agrochemical research. Its electronic properties make it suitable for use in organic semiconductors and optoelectronic devices. Furthermore, derivatives of this compound have been investigated for their potential as antimicrobial agents, addressing the growing challenge of antibiotic resistance.

The chemical synthesis of 3-bromoimidazo[1,2-c]pyrimidine typically involves multi-step processes starting from readily available precursors. One common synthetic route involves the condensation of 2-amino-5-bromobenzaldehyde with guanidine hydrochloride under acidic conditions, followed by cyclization to form the imidazopyrimidine core. Subsequent bromination or other functional group transformations yield the desired product with high purity and yield.

The analytical characterization of 3-bromoimidazo[1,2-c]pyrimidine is performed using standard spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and infrared (IR) spectroscopy. These methods provide definitive evidence of its molecular structure and purity. High-performance liquid chromatography (HPLC) is often employed for purification and quantitative analysis.

The safety profile of 3-bromoimidazo[1,2-c]pyrimidine is an important consideration in its handling and application. While it is not classified as a hazardous material under standard regulatory guidelines, appropriate laboratory practices should be followed to ensure safe usage. Personal protective equipment (PPE) such as gloves and safety goggles is recommended during handling.

In conclusion,3-bromoimidazo[1,2-c]pyrimidine represents a structurally intriguing and biologically active compound with far-reaching implications in pharmaceutical research. Its versatility as a synthetic intermediate and its potential therapeutic applications underscore its importance in modern drug discovery efforts. As research continues to uncover new functionalities and applications for this compound,3-bromoimidazo[1,2-c]pyrimidine is poised to remain a cornerstone in medicinal chemistry innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)